An <i>Ex-Vivo</i> Culture System of Ovarian Cancer Faithfully Recapitulating the Pathological Features of Primary Tumors
Farhana Ishrat Ghani,
Kasumi Dendo,
Reiko Watanabe,
Kenji Yamada,
Yuki Yoshimatsu,
Takashi Yugawa,
Tomomi Nakahara,
Katsuyuki Tanaka,
Hiroshi Yoshida,
Masayuki Yoshida,
Mitsuya Ishikawa,
Naoki Goshima,
Tomoyasu Kato,
Tohru Kiyono
Affiliations
Farhana Ishrat Ghani
Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tokyo 104-0045, Japan
Kasumi Dendo
Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tokyo 104-0045, Japan
Reiko Watanabe
Department of Cell Culture Technology, National Cancer Center Research Institute, Tokyo 104-0045, Japan
Kenji Yamada
Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tokyo 104-0045, Japan
Yuki Yoshimatsu
Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tokyo 104-0045, Japan
Takashi Yugawa
Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tokyo 104-0045, Japan
Tomomi Nakahara
Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tokyo 104-0045, Japan
Katsuyuki Tanaka
Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tokyo 104-0045, Japan
Hiroshi Yoshida
Pathology Division, National Cancer Center Hospital, Tokyo 104-0045, Japan
Masayuki Yoshida
Pathology Division, National Cancer Center Hospital, Tokyo 104-0045, Japan
Mitsuya Ishikawa
Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan
Naoki Goshima
Molecular Profiling Research Center for Drug Discovery, National Institute of Advanced Industrial Science and Technology, 2-4-7 Aomi, Koto-ku, Tokyo 135-0064, Japan
Tomoyasu Kato
Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan
Tohru Kiyono
Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tokyo 104-0045, Japan
The success rate of establishing human cancer cell lines is not satisfactory and the established cell lines often do not preserve the molecular and histological features of the original tissues. In this study, we developed a novel culture method which can support proliferation of almost all primary epithelial ovarian cancer cells, as well as primary normal human oviductal epithelial cells. Cancer cells from fresh or frozen specimens were enriched by the anti-EpCAM antibody-conjugated magnetic beads, plated on Matrigel-coated plate and cultivated under the optimized culture conditions. Seventeen newly established ovarian cancer cell lines, which included all four major histotypes of ovarian cancer, were confirmed to express histotype-specific markers in vitro. Some of the cell lines from all the four histotypes, except mucinous type, generated tumors in immune-deficient mice and the xenograft tumor tissues recapitulated the corresponding original tissues faithfully. Furthermore, with poorly tumorigenic cell lines including mucinous type, we developed a novel xenograft model which could reconstruct the original tissue architecture through forced expression of a set of oncogenes followed by its silencing. With combination of the novel culture method and cell-derived xenograft system, virtually every epithelial ovarian cancer can be reconstituted in mice in a timely fashion.